Related Experiment Video
Updated: Apr 27, 2026

Detection of Aggregation-Prone Behavior in Mutant P53 V157F Breast Cancer Cells Using Multipoint Thioflavin T Fluorescence
Published on: December 30, 2025
Mutant p53 gains new function in promoting inflammatory signals by repression of the secreted interleukin-1 receptor
V Ubertini1, G Norelli1, D D'Arcangelo2
1Experimental Oncology Laboratories, Regina Elena National Cancer Institute, Rome, Italy.
Abstract:
The TP53 tumor-suppressor gene is frequently mutated in human cancer. Missense mutations can add novel functions (gain-of-function, GOF) that promote tumor malignancy. Here we report that mutant (mut) p53 promotes tumor malignancy by suppressing the expression of a natural occurring anti-inflammatory cytokine, the secreted interleukin-1 receptor antagonist (sIL-1Ra, IL1RN). We show that mutp53 but not wild-type (wt) p53 suppresses the sIL-1Ra production in conditioned media of cancer cells. Moreover, mutp53, but not wtp53, binds physically the sIL-1Ra promoter and the protein-protein interaction with the transcriptional co-repressor MAFF (v-MAF musculoaponeurotic fibrosarcoma oncogene family, protein F) is required for mutp53-induced sIL-1Ra suppression. Remarkably, when exposed to IL-1 beta (IL-1β) inflammatory stimuli, mutp53 sustains a ready-to-be-activated in vitro and in vivo cancer cells' response through the sIL-1Ra repression. Taken together, these results identify sIL-1Ra as a novel mutp53 target gene, whose suppression might be required to generate a chronic pro-inflammatory tumor microenvironment through which mutp53 promotes tumor malignancy.
Insights
Mutant p53 (mutp53) promotes cancer by suppressing the anti-inflammatory interleukin-1 receptor antagonist (IL1RN). This suppression, involving direct promoter binding and MAFF interaction, creates a pro-inflammatory environment, driving tumor malignancy.
Area of Science:
- Oncology
- Molecular Biology
- Immunology
Background:
- The TP53 tumor-suppressor gene is frequently mutated in human cancers.
- Gain-of-function (GOF) mutations in p53 can confer novel oncogenic functions, promoting tumor malignancy.
- A chronic pro-inflammatory tumor microenvironment is associated with increased cancer progression.
Purpose of the Study:
- To investigate the role of mutant p53 (mutp53) in regulating the expression of the anti-inflammatory cytokine secreted interleukin-1 receptor antagonist (sIL-1Ra).
- To elucidate the molecular mechanisms by which mutp53 influences sIL-1Ra production and its impact on tumor malignancy.
- To determine if sIL-1Ra suppression by mutp53 contributes to a pro-inflammatory tumor microenvironment.
Main Methods:
- Assessed sIL-1Ra production in cancer cell conditioned media comparing mutant p53 (mutp53) and wild-type p53 (wtp53) expressing cells.
- Performed chromatin immunoprecipitation (ChIP) assays to investigate mutp53 binding to the sIL-1Ra promoter.
- Utilized co-immunoprecipitation to examine the interaction between mutp53 and the transcriptional co-repressor MAFF.
Main Results:
- Mutant p53, but not wild-type p53, significantly suppresses the production of sIL-1Ra in cancer cells.
- Mutant p53 directly binds to the promoter region of the IL1RN gene (encoding sIL-1Ra).
- The suppression of sIL-1Ra by mutp53 requires its physical interaction with the transcriptional co-repressor MAFF.
Conclusions:
- Secreted interleukin-1 receptor antagonist (sIL-1Ra) is identified as a novel target gene of mutant p53.
- Suppression of sIL-1Ra by mutp53 contributes to a chronic pro-inflammatory tumor microenvironment.
- Mutant p53-mediated sIL-1Ra suppression is a mechanism promoting tumor malignancy.
Related Concept Videos
Abnormal Proliferation
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The...
The JAK-STAT Signaling Pathway
Inflammatory Response
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...

